- American City Business Journals•4 hours ago
Exelixis Inc. was the king of biobucks, pumping up the South San Francisco biotech company's coffers and pushing its portfolio of drugs forward with Big Pharma partners such as GlaxoSmithKline and Bristol-Myers ...
- optionMONSTER•6 hours ago
Exelixis has been ripping higher for months, and traders are wagering on more gains. optionMONSTER's monitoring system detected the purchase of more than 4,000 October 12 calls for $1.35 to $1.50 yesterday. ...
Exelixis, Inc. (EXEL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||12.89 x 500|
|Ask||12.90 x 1600|
|Day's Range||12.13 - 12.99|
|52wk Range||3.55 - 15.58|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-15.36|
|Avg Vol (3m)||6,439,931|
|Dividend & Yield||N/A (N/A)|